Showing results (61-70 of 219) with videos related to
Sort By:
Pageof 22
Cancer|July 29, 2009
Vascular endothelial growth factor in the management of hepatocellular carcinoma: a review of literatureAhmed O Kaseb, Amr Hanbali, Matthew Cotant, et al.Cancer|October 24, 2007
Response to dual blockade of epidermal growth factor receptor (EGFR) and cycloxygenase-2 in nonsmall cell lung cancer may be dependent on the EGFR mutational status of the tumorShirish M Gadgeel, Shadan Ali, Philip A Philip, et al.Carcinogenesis|May 29, 2012
Re-expression of miR-200 by novel approaches regulates the expression of PTEN and MT1-MMP in pancreatic cancerOmar Soubani, Azfur S Ali, Farah Logna, et al.Critical Reviews in Oncology/Hematology|March 21, 2012
Metabolomics in cancer: a bench-to-bedside intersectionWederson M Claudino, Priscila H Goncalves, Angelo di Leo, et al.Expert Opinion on Therapeutic Targets|April 30, 2010
PAR-4 as a possible new target for pancreatic cancer therapyAsfar S Azmi, Philip A Philip, Syed F Zafar, et al.Cancers|August 7, 2019
DNA-Methylation-Caused Downregulation of miR-30 Contributes to the High Expression of XPO1 and the Aggressive Growth of Tumors in Pancreatic Ductal AdenocarcinomaAsfar S Azmi, Yiwei Li, Amro Aboukameel, et al.Cancer Treatment Reviews|September 10, 2008
Exploitation of protein kinase C: a useful target for cancer therapyAshhar S Ali, Shadan Ali, Bassel F El-Rayes, et al.Journal of Cellular Physiology|June 13, 2012
The role of cancer stem cells and miRNAs in defining the complexities of brain metastasisAshhar S Ali, Aamir Ahmad, Shadan Ali, et al.Cancers|August 27, 2021
Non-Coding RNAs in Pancreatic Cancer Diagnostics and Therapy: Focus on lncRNAs, circRNAs, and piRNAsYiwei Li, Mohammed Najeeb Al Hallak, Philip A Philip, et al.Anticancer Research|July 31, 2012
Association between COX-2 expression and effectiveness of COX-2 inhibitors in a phase II trial in patients with metastatic colorectal adenocarcinomaKhaldoun Almhanna, Bassel El-Rayes, Seema Sethi, et al.Pageof 22